Allscripts U.K. Client Gloucestershire Hospitals Achieves Successful Go-Live with E-Observations Solution Amidst COVID-19 Pandemic

AllscriptsGloucestershire Hospitals NHS Foundation Trust, located in the United Kingdom, has successfully gone live with the latest addition to its Allscripts electronic health record, despite the ongoing novel coronavirus outbreak.

The Trust decided to deploy the Sunrise EHR as a 'clinical wrap' around its existing patient administration system last year and went live with nursing documentation and risk assessments just five months later.

On March 17, 2020, the Trust added the e-observations functionality, which includes automatic calculation of NEWS2, the national early warning score designed to pick up patients at risk of deterioration. The implementation of NEWS2 is immediately helping the Trust manage patients during the COVID-19 outbreak. Gloucestershire Hospitals has also added icons to its patient tracking board to identify patients with COVID-19 and made results available through the system.

"At a time when we were in the midst of COVID-19 planning, I was unbelievably proud of our nursing staff for their impressive implementation of e-observations and commitment to making it work. This has been good for our patients and good for our clinical teams," said Professor Steve Hams, the Trust’s Director of Quality and Chief Nurse.

"We knew that moving patient observations to Sunrise EHR would bring huge benefits in our two acute hospitals and had planned our launch for March. So when the COVID-19 pandemic hit the UK, we needed to make a quick decision about whether or not to go ahead. We held our nerve and put extra staff on our wards to make sure we got this right, at a challenging time for our hospitals," said Mark Hutchinson, executive CDIO.

"Having e-observations in place has proved essential in managing our patients during the coronavirus pandemic. Our acute care response teams are able to manage caseloads, senior nursing staff can use the data to manage staffing deployment, and we’re able to track the numbers and locations of patients who are being supported by oxygen."

The Allscripts U.K. team has moved fast to support Trusts like Gloucestershire Hospitals that want to proceed with go-lives that will help their staff and patients through the pandemic. It has created a Go-Live Virtual Office with a 24/7 virtual meeting room with voice and video capability, structured documents and screen sharing tools.

The office is connected to a floorwalking messaging app, so team members can be aware of issues as they are identified on wards and clinics, before they are logged into help-desk systems.

For the Gloucestershire Hospitals go-live, the virtual office was staffed with a wide range of team members based in different countries around the globe, so the Trust team could visit at any time.

"As NHS acute Trusts begin to deal with more and more people with COVID-19, the flexibility of Sunrise is proving to be a key tool for helping them to identify and manage these patients," said Richard Strong, Allscripts Managing Director, EMEA. "It was a brave decision for Gloucestershire Hospitals NHS Foundation Trust to introduce new functionality to record patient observations and escalate the management of deteriorating patients amid the huge organizational change required to prepare for the pandemic. But it was absolutely the right decision, and one Allscripts was determined to support. We moved rapidly to new ways of working to fully support go-lives 24/7, without risking the health of our staff, NHS staff or patients by undertaking traditional support and floor-walking activities. We were already moving toward this way of working before the COVID-19 shutdown, but we accelerated our schedule to push through remote working in time for the Gloucestershire Hospitals go-live. We are now using these tools to support other NHS customers that want to go-ahead with functionality that will help them, their staff and patients at this exceptionally difficult time."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...